CapsoVision, Inc
CV · Electromedical & Electrotherapeutic Apparatus · 50.0M shares · EDGAR filings ↗
Reference price $4.17 · est. market cap ~$208M — last insider purchase, 2025-07-03 (estimated from the dated SEC Form 4 price × shares outstanding — not a live quote)
Grade
D45CapsoVision — capsule-endoscopy device maker running losses.
Strengths
- Strong liquidity (current 3.8); differentiated wireless-capsule imaging
Risks
- Operating margin -188%; ROE -191% (25th pct)
- Adoption/reimbursement and cash-burn risk
Notable findings
- Going concern• Our audited financial statements for the years ended December 31, 2025 and December 31, 2024 include a footnote raising substantial doubt about our ability to continue as a “going concern” and we wi
- Net lossNet loss (net margin -186.8%)
- Cash burnNegative free cash flow (-23.0M)
- Revenue declineRevenue -28.7% YoY
Quarterly revenue
Last 4 quarters · from SEC filings.
Key metrics
Gross margin
52.9%
Operating margin
-188.3%
Net margin
-186.8%
Return on equity
-190.9%
Return on assets
-139.4%
Revenue growth (QoQ)
-28.7%
Current ratio
3.8×
Free cash flow
-$23M
EBITDA
-$25M
Tangible book value
$13M
Stock comp / revenue
6.1%
Insider transactions · last 18 months
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-05-05 | Atkinson Douglas Patrick | Option exercise | 35K | $0.57 |
| 2026-05-04 | Atkinson Douglas Patrick | Option exercise | 6.5K | $0.57 |
| 2026-05-04 | Atkinson Douglas Patrick | Option exercise | 36K | $0.29 |
| 2026-05-04 | Atkinson Douglas Patrick | Option exercise | 30K | $0.37 |
| 2025-12-31 | Harari Michele | Option exercise | 2.9K | $10.69 |
| 2025-12-31 | GOUW JULIA S | Option exercise | 2.9K | $10.69 |
| 2025-12-31 | Tsai Chen Lung | Option exercise | 2.9K | $10.69 |
| 2025-12-31 | Imperial Joanne Carol | Option exercise | 2.9K | $10.69 |
| 2025-12-31 | Kuo Hui Ying | Option exercise | 2.9K | $10.69 |
| 2025-12-31 | King Wen-Herng Henry | Option exercise | 2.9K | $10.69 |
| 2025-08-18 | Petersen Rebecca Ann | Option exercise | 25K | $0.37 |
| 2025-07-03 | Tsai Chen Lung | Buy | 20 | $4.17 |
| 2025-07-03 | HARARI ELIYAHOU ET AL | Conversion | 3.2M | — |
| 2025-07-03 | HARARI ELIYAHOU ET AL | Conversion | 518K | — |
| 2025-07-03 | HARARI ELIYAHOU ET AL | Conversion | 518K | — |
| 2025-07-03 | HARARI ELIYAHOU ET AL | Conversion | 3.2M | — |
| 2025-07-03 | HARARI ELIYAHOU ET AL | Conversion | 518K | — |
| 2025-07-03 | HARARI ELIYAHOU ET AL | Conversion | 518K | — |
| 2025-07-03 | King Wen-Herng Henry | Conversion | 21K | — |
| 2025-07-03 | Kuo Hui Ying | Conversion | 10K | — |
| 2025-07-03 | Tsai Chen Lung | Conversion | 91K | — |
| 2025-07-03 | Wang Kang-Huai | Conversion | 447K | — |
All non-derivative Form 4 activity (SEC), newest first.
Notable events (8-K)
| Date | Items | |
|---|---|---|
| 2026-06-12 | Shareholder vote | filing ↗ |
| 2026-05-14 | ResultsExhibits | filing ↗ |
| 2026-03-26 | ResultsExhibits | filing ↗ |
| 2026-03-20 | Material agreementResults3.02Reg FDOtherExhibits | filing ↗ |
| 2026-03-13 | Material agreementExhibits | filing ↗ |
| 2025-12-29 | OtherExhibits | filing ↗ |
| 2025-11-13 | ResultsExhibits | filing ↗ |
| 2025-11-10 | OtherExhibits | filing ↗ |
Recent filings
| Form | Filed | Period | Accession |
|---|---|---|---|
| 8-K | 2026-06-12 | 2026-06-11 | 0001378325-26-000023 ↗ |
| 10-Q | 2026-05-14 | 2026-03-31 | 0001378325-26-000021 ↗ |
| 8-K | 2026-05-14 | 2026-05-14 | 0001378325-26-000019 ↗ |
| 10-K | 2026-03-26 | 2025-12-31 | 0001378325-26-000010 ↗ |
| 8-K | 2026-03-26 | 2026-03-26 | 0001378325-26-000008 ↗ |
| 8-K | 2026-03-20 | 2026-03-20 | 0001378325-26-000004 ↗ |
| 8-K | 2026-03-13 | 2026-03-13 | 0001378325-26-000002 ↗ |
| 8-K | 2025-12-29 | 2025-12-29 | 0001378325-25-000043 ↗ |
| 8-K | 2025-11-13 | 2025-11-13 | 0001378325-25-000039 ↗ |
| 10-Q | 2025-11-13 | 2025-09-30 | 0001378325-25-000040 ↗ |
| 8-K | 2025-11-10 | 2025-11-10 | 0001378325-25-000031 ↗ |
| 8-K | 2025-11-03 | 2025-11-03 | 0001378325-25-000027 ↗ |